$GNPX's platform technologies are designed to administer cancer fighting genes by encapsulating them into nanoscale hollow spheres called nanovesicles, which are then administered intravenously and taken up by tumor cells where they express proteins that are missing or found in low quantities. We hold a portfolio of 30 issued and 2 pending patents covering our technologies and targeted molecular therapies. https://www.genprex.com/technology